| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.38 | 1e-24 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-21 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |